Celularity Inc·4

Sep 15, 6:50 PM ET

Mirakhur Beloo 4

4 · Celularity Inc · Filed Sep 15, 2021

Insider Transaction Report

Form 4
Period: 2021-09-13
Mirakhur Beloo
EVP, Clinical Development
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-13+125,000125,000 total
    Exercise: $6.87Exp: 2031-09-13Class A Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, September 13, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and 1/48 of the total number of shares each month thereafter over the following three years, such that the options will be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer on each such date.

Documents

1 file
  • 4
    ownership.xmlPrimary